2022. Patient-Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis in Real-world Settings: PROAK Study Protocol. SKIN The Journal of Cutaneous Medicine. 6, 2 (Mar. 2022), s19. DOI:https://doi.org/10.25251/skin.6.supp.19.